Drug profile

The FDA adverse-event record for Liquid Dish Soap

180 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Liquid Dish Soap. See the species affected, top reactions, and outcomes below.

180
adverse-event reports
8.9%
death-coded share
Dog
most-reported species
102
Lack of efficacy (ectoparasite) - flea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
180
Total Reports
16
Deaths Reported
8.9%
Death Rate

Active Ingredients

Liquid Dish Soap

Administration Routes

TopicalUnknownOral

Species Affected

Dog 102
Cat 76
Human 2

Most Affected Breeds

Domestic Shorthair 37
Dog (unknown) 16
Siamese 9
Domestic Mediumhair 9
Chihuahua 9
Cat (unknown) 9
Shih Tzu 5
Pit Bull 5
Shepherd Dog - German 5
Spitz - German Pomeranian 4

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 102
Drug dose administration interval too long 18
Lethargy (see also Central nervous system depression in 'Neurological') 16
Pruritus 15
Ataxia 15
Behavioural disorder NOS 14
Hypersalivation 13
Anorexia 11
Vomiting 10
Death 10
Seizure NOS 9
Hyperactivity 8

Outcome Breakdown

Outcome Unknown
141 (78.3%)
Recovered/Normal
17 (9.4%)
Died
11 (6.1%)
Ongoing
6 (3.3%)
Euthanized
5 (2.8%)

Liquid Dish Soap Adverse Event Insights

180 reports name Liquid Dish Soap; 16 recorded a death outcome (8.9% of reported events, not a population-level mortality rate). Active ingredient: Liquid Dish Soap. Administration routes: Topical, Unknown, Oral.

By species: Dog (102 reports), Cat (76 reports), Human (2 reports). By breed: Domestic Shorthair (37), Dog (unknown) (16), Siamese (9).

Leading clinical signs: Lack of efficacy (ectoparasite) - flea (102), Drug dose administration interval too long (18), Lethargy (see also Central nervous system depression in 'Neurological') (16), Pruritus (15). Outcome, 180 coded reports: Outcome Unknown leads at 78.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.